Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention
- PMID: 21595514
- DOI: 10.1089/rej.2010.1141
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention
Abstract
Cancer in elderly patients is an increasingly common problem. Older patients have more co-morbidity, therefore the toxic effects of chemotherapy treatment are less tolerable compared to younger patients. Platinum-based compounds (PBCs) are commonly used cytotoxic agents in the treatment of several solid tumors; however, their application is still limited in elderly patients, due to the risks in cardiovascular toxicity. The increased risk for myocardial ischemia, stroke, and vascular thrombosis linked with PBCs treatment is mainly due to reactive oxygen species (ROS) production and the subsequent induction of oxidative stress and switch to a prothrombotic condition. Recently, studies have shown a different genetic susceptibility in cardiovascular toxicity induced by therapy with PBCs. Antioxidants, such as vitamin E, selenium, lycopene, melatonin, and resveratrol, have been implicated in cancer treatment by their property to suppress the oxidant injury. Resveratrol, especially, has been shown to increase the antineoplastic activity of cisplatin. In addition, resveratrol's ability to activate the sirtuin1 (SIRT1) pathway has been heavily implicated in the mechanisms controlling longevity and quality of life in the aged population. This article reviews the current state of treatment with PBCs and their associated risk for cardiovascular disease. It discusses the most powerful antioxidant supplementation options as a possible strategy to reduce the cardiovascular toxicity effects of chemotherapy in the elderly.
Similar articles
-
The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.Ther Adv Cardiovasc Dis. 2010 Jun;4(3):165-83. doi: 10.1177/1753944710368205. Epub 2010 Apr 16. Ther Adv Cardiovasc Dis. 2010. PMID: 20400494 Review.
-
New concept in nutrition for the maintenance of the aging eye redox regulation and therapeutic treatment of cataract disease; synergism of natural antioxidant imidazole-containing amino acid-based compounds, chaperone, and glutathione boosting agents: a systemic perspective on aging and longevity emerged from studies in humans.Am J Ther. 2010 Jul-Aug;17(4):373-89. doi: 10.1097/MJT.0b013e3181d6b6c3. Am J Ther. 2010. PMID: 20463577 Review.
-
Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.Am J Cardiol. 2008 May 22;101(10A):58D-68D. doi: 10.1016/j.amjcard.2008.02.010. Am J Cardiol. 2008. PMID: 18474276 Review.
-
Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).Lung Cancer. 2006 Aug;53(2):171-6. doi: 10.1016/j.lungcan.2006.04.006. Epub 2006 Jun 6. Lung Cancer. 2006. PMID: 16757059
-
Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer.Cancer. 2010 Dec 15;116(24):5628-36. doi: 10.1002/cncr.25300. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737565
Cited by
-
Incidence of cardiovascular mortality among head and neck cancer patients.Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4351-4361. doi: 10.1007/s00405-024-08670-5. Epub 2024 May 9. Eur Arch Otorhinolaryngol. 2024. PMID: 38724856
-
Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.Int J Mol Sci. 2017 Apr 27;18(5):916. doi: 10.3390/ijms18050916. Int J Mol Sci. 2017. PMID: 28448438 Free PMC article.
-
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.Cancer. 2016 Mar 1;122(5):712-21. doi: 10.1002/cncr.29801. Epub 2015 Nov 30. Cancer. 2016. PMID: 26618338 Free PMC article.
-
Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma Treatment.Pharmaceuticals (Basel). 2019 May 18;12(2):76. doi: 10.3390/ph12020076. Pharmaceuticals (Basel). 2019. PMID: 31109098 Free PMC article.
-
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Front Physiol. 2018 Mar 7;9:167. doi: 10.3389/fphys.2018.00167. eCollection 2018. Front Physiol. 2018. PMID: 29563880 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical